About the event:
Attend this Seminar to learn about innovation at Astellas, including the Company’s therapeutic and platform technology focus areas, science-led investment strategy and collaborative partnering approach – launching the call for Golden Ticket Competition entries to help accelerate innovative life science start-ups into real businesses that can bring value to patients.
Dr. Matsumoto is the president of AVM, the wholly-owned venture capital organization within Astellas Pharma Inc. (Astellas). He established Astellas Innovation Management LLC, headquartered in Cambridge, Massachusetts, to explore emerging innovation in life sciences and served as its president for two years until March 2018. He also previously served as divisional senior vice president, Innovation & Incubation Research Labs, Drug Discovery Research, Astellas Pharma Inc. in Japan.